Today's Change
+0.85%
AI Sentiment
59%
Sector AnalysisLive data
Materials Sector Outlook
The Materials sector is up 0.85% today with neutral sentiment across 16 recent news articles. Top movers include $CDTTW (+65.33%), $ERNAW (+63.87%), $TMCWW (+60.68%).
Bullish Factors
- No strong bullish signals detected
Risk Factors
- No strong bearish signals detected
Stocks in Materials
198 stocks| Symbol | Company | Change |
|---|---|---|
| $REVBW | Revelation Biosciences Inc - Warrants(10/01/2027) | +0.00% |
| $HUMAW | Humacyte Inc - Warrants (27/08/2026) | +5.13% |
| $ERNAW | Ernexa Therapeutics Inc Warrants | +63.87% |
| $CINGW | Cingulate Inc - Warrants (03/12/2026) | -10.38% |
| $BIVIW | BioVie Inc Warrant | +9.38% |
| $CDIOW | Cardio Diagnostics Holdings Inc - Warrants (01/12/2026) | -11.72% |
| $BCTXL | BriaCell Therapeutics Corp Warrants | +7.53% |
| $GRMLW | Greenland Mines Ltd - Warrants(21/06/2029) | +11.00% |
| $CITR | General Enterprise Ventures Inc | +3.17% |
| $SRZNW | Surrozen Inc - Warrants (01/08/2026) | +5.00% |
| $ORGNW | Origin Materials Inc - Warrants (23/06/2026) | -18.18% |
| $ASBPW | Aspire Biopharma Holdings Inc - Warrants (18/02/2030) | +7.88% |
| $SEE | Sealed Air Corp. | +0.00% |
| $KTTAW | Pasithea Therapeutics Corp - Warrants (11/08/2026) | -1.23% |
| $AIMDW | Ainos Inc - Warrants (29/07/2027) | -24.11% |
Materials News
805 articles
GlobeNewswire Inc.40d ago
Teva gagne du terrain dans le domaine des médicaments biosimilaires grâce à l’approbation accordée par la FDA pour PONLIMSI™ (dénosumab-adet) et à l’acceptation d’un double dossier pour un candidat biosimilaire à Xolair® (omalizumab)
GlobeNewswire Inc.40d ago
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
GlobeNewswire Inc.40d ago
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.40d ago
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate
Benzinga40d ago
REGENXBIO Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RGNX
Benzinga40d ago
RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm
Benzinga40d ago
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
GlobeNewswire Inc.40d ago
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT
GlobeNewswire Inc.40d ago
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST
The Motley Fool40d ago
Oil and Fertilizer Prices May Soon Have Ripple Effects on These 3 Commodities Stocks
GlobeNewswire Inc.41d ago
INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. (RARE) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - RGRD Law
Market Sentiment
Neutral
59% Sentiment Score
Sector Stats
Total Stocks198
News Today16
Avg Volume1.3M
AI SentimentNeutral